With a triumphant Zohran Mamdani taking over as New York City mayor Jan. 1, many of my patients tell me they finally feel ...

Turkey has been watching closely, not out of solidarity or rivalry, but recognition. Ankara is undergoing a parallel test, ...

Immatics has innovative TCR therapies, strong cash position, and expanding clinical pipeline targeting solid tumors. Read for ...

From a security perspective, the transition from 2025 to 2026 shows that risks in Türkiye’s immediate neighborhood have taken ...

For more than 100 years, Alzheimer’s disease has been treated as a one‑way descent, a diagnosis that could be delayed at best ...

Today, Eritrean forces control large swathes of Ethiopian territory as a direct result of Asmara’s involvement in the ...

How Pakistan’s startup boom collapsed from 2020–2025, exposing why VC-led hypergrowth failed and what founders must do to ...

State lawmakers are quietly preparing the next round of fights over “smart guns,” shifting from abstract debates about ...

This clinical-stage biotech focused on cystic fibrosis therapies reported a notable insider sale amid a year of sharp ...

In 2026, here's what you can expect from the AI industry: new architectures, smaller models, world models, reliable agents, ...